The human epidermal growth factor receptor 2 (HER2, also known as ERBB2), as one of the rare driver genes in NSCLC, has a mutation rate ranging from 1.4% to 6.7% in Asian populations.6, 7. Here, ERBB2 is linked to non-small cell lung carcinoma.